PHF12 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.890200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.968600E-01
Normal-vs-Stage2
3.875000E-01
Normal-vs-Stage3
2.083600E-01
Normal-vs-Stage4
2.739800E-01
Stage1-vs-Stage2
1.357170E-01
Stage1-vs-Stage3
1.612270E-02
Stage1-vs-Stage4
2.751000E-01
Stage2-vs-Stage3
7.008400E-02
Stage2-vs-Stage4
9.942400E-01
Stage3-vs-Stage4
6.487900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.912000E-01
Normal-vs-AfricanAmerican
4.386200E-01
Normal-vs-Asian
1.029990E-01
Caucasian-vs-AfricanAmerican
7.547600E-01
Caucasian-vs-Asian
2.855800E-01
AfricanAmerican-vs-Asian
4.038600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.779400E-01
Normal-vs-Female
4.053400E-01
Male-vs-Female
5.498200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.848800E-01
Normal-vs-Age(41-60Yrs)
4.582200E-01
Normal-vs-Age(61-80Yrs)
3.455700E-02
Normal-vs-Age(81-100Yrs)
3.141200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.912580E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.262960E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.372000E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.506200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.025900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.512800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.069600E-01
Normal-vs-Daily Drinker
4.016200E-02
Normal-vs-Weekly Drinker
1.143620E-01
Normal-vs-Occasional Drinker
4.993000E-01
Normal-vs-Social Drinker
2.139600E-01
Non Drinker-vs-Daily Drinker
7.106400E-01
Non Drinker-vs-Weekly Drinker
6.339200E-01
Non Drinker-vs-Occasional Drinker
2.808400E-02
Non Drinker-vs-Social Drinker
2.690500E-02
Daily Drinker-vs-Weekly Drinker
8.734800E-01
Daily Drinker-vs-Occasional Drinker
9.215500E-02
Daily Drinker-vs-Social Drinker
8.497800E-02
Weekly Drinker-vs-Occasional Drinker
2.236600E-01
Weekly Drinker-vs-Social Drinker
2.086200E-01
Occasional Drinker-vs-Social Drinker
8.892200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.230000E-02
Normal-vs-Grade 2
1.342850E-03
Normal-vs-Grade 3
1.522330E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.709800E-01
Grade 1-vs-Grade 3
8.856200E-01
Grade 1-vs-Grade 4
4.230000E-02
Grade 2-vs-Grade 3
4.468800E-01
Grade 2-vs-Grade 4
1.342850E-03
Grade 3-vs-Grade 4
1.522330E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.472500E-02
Normal-vs-NonDiabetic
4.016000E-01
Diabetic-vs-NonDiabetic
1.465160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.945640E-01
Normal-vs-NoPancreatitis
3.639600E-01
Pancreatitis-vs-NoPancreatitis
2.620600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.962100E-02
Normal-vs-N1
3.848600E-01
N0-vs-N1
9.695200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.210400E-01
Normal-vs-TP53-NonMutant
5.558200E-01
TP53-Mutant-vs-TP53-NonMutant
6.703200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
